Jia et al. [33] developed a hydrogel dressing incorporating dopamine nanoparticles, FAK inhibitors, and other components, which can alleviate symptoms in mouse AD models by scavenging ROS and inhibiting the FAK signaling pathway. The gene discussed is PTK2; the disease is Alzheimer disease.